Regarding the activation of tumor angiogenesis, the most prominent targets of HIF-1α are vascular endothelial growth factor (VEGF), calcitonin receptor-like receptor (CRLR), stem cell factor (SCF) and angiopoietin 2 (ANGPT2) [185,186,187,188]. The gene discussed is KITLG; the disease is neoplasm.